Objective Assessment of Cancer Biomarkers Using Semi-Rare Event Detection

od Jeroen A. W. M. van der Laak, Albertus G. Siebers, Sabine A. A. P. Aalders, Johanna M. M. Grefte, Peter C. M. de Wilde, Johan Bulten
Izdano 2007-01-01

Successful Combination of Sunitinib and Girentuximab in Two Renal Cell Carcinoma Animal Models: A Rationale for Combination Treatment of Patients with Advanced RCC

od Jeannette C. Oosterwijk-Wakka, Mirjam C.A. de Weijert, Gerben M. Franssen, William P.J. Leenders, Jeroen A.W.M. van der Laak, Otto C. Boerman, Peter F.A. Mulders, Egbert Oosterwijk
Izdano 2015-02-01